NCT00443326View on ClinicalTrials.gov

AMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis Subjects

PHASE2CompletedINTERVENTIONAL

Enrollment

22

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

May 31, 2010

Conditions

Psoriasis

Interventions

DRUG

AMG 714

Dosing Regimen is 6 Doses over 3 Months

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY